1. Home
  2. CVAC vs SEDG Comparison

CVAC vs SEDG Comparison

Compare CVAC & SEDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • SEDG
  • Stock Information
  • Founded
  • CVAC 2000
  • SEDG 2006
  • Country
  • CVAC Germany
  • SEDG Israel
  • Employees
  • CVAC N/A
  • SEDG N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • SEDG Semiconductors
  • Sector
  • CVAC Health Care
  • SEDG Technology
  • Exchange
  • CVAC Nasdaq
  • SEDG Nasdaq
  • Market Cap
  • CVAC 637.1M
  • SEDG 682.3M
  • IPO Year
  • CVAC 2020
  • SEDG 2015
  • Fundamental
  • Price
  • CVAC $2.95
  • SEDG $14.37
  • Analyst Decision
  • CVAC Hold
  • SEDG Hold
  • Analyst Count
  • CVAC 3
  • SEDG 26
  • Target Price
  • CVAC $10.00
  • SEDG $26.82
  • AVG Volume (30 Days)
  • CVAC 523.1K
  • SEDG 4.9M
  • Earning Date
  • CVAC 11-12-2024
  • SEDG 11-06-2024
  • Dividend Yield
  • CVAC N/A
  • SEDG N/A
  • EPS Growth
  • CVAC N/A
  • SEDG N/A
  • EPS
  • CVAC N/A
  • SEDG N/A
  • Revenue
  • CVAC $70,565,734.00
  • SEDG $1,046,751,000.00
  • Revenue This Year
  • CVAC $738.59
  • SEDG N/A
  • Revenue Next Year
  • CVAC N/A
  • SEDG $26.62
  • P/E Ratio
  • CVAC N/A
  • SEDG N/A
  • Revenue Growth
  • CVAC 75.11
  • SEDG N/A
  • 52 Week Low
  • CVAC $2.22
  • SEDG $10.24
  • 52 Week High
  • CVAC $5.28
  • SEDG $103.15
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 49.55
  • SEDG 51.49
  • Support Level
  • CVAC $3.17
  • SEDG $12.27
  • Resistance Level
  • CVAC $3.56
  • SEDG $14.95
  • Average True Range (ATR)
  • CVAC 0.18
  • SEDG 1.34
  • MACD
  • CVAC 0.01
  • SEDG 0.14
  • Stochastic Oscillator
  • CVAC 24.69
  • SEDG 54.69

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About SEDG SolarEdge Technologies Inc.

SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.

Share on Social Networks: